ConductScience.org, home

Paper29428486

Intra-articular knee implantation of autologous bone marrow-derived mesenchymal stromal cells in rheumatoid arthritis patients with knee involvement: Results of a randomized, triple-blind, placebo-controlled phase 1/2 clinical trial.

Shadmanfar S and 13 others. Cytotherapy, 2018. Cited by 81 papers, by iCite.

Cite this record

ConductScience Library. Intra-articular knee implantation of autologous bone marrow-derived mesenchymal stromal cells in rheumatoid arthritis patients with knee involvement: Results of a randomized, triple-blind, placebo-controlled phase 1/2 clinical trial. Papers, record 29428486. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/29428486

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Intra-articular knee implantation of autologous bone marrow-derived mesenchymal stromal cells in rheumatoid arthritis patients with knee involvement: Results of a randomized, triple-blind, placebo-controlled phase 1/2 clinical trial.
PubMed
Journal
Cytotherapy
PubMed
Year
2018
PubMed
Publication types
Clinical Trial, Phase I, Clinical Trial, Phase II, Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
81
iCite
Relative citation ratio, by iCite
3.9
iCite
Revised in PubMed
2019-09-13
PubMed

Authors14

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Shadmanfar SSoraya
2Labibzadeh NNarges
3Emadedin MMohsen
4Jaroughi NNeda
5Azimian VVajiheh
6Mardpour SSoura
7Kakroodi FAFatemeh Abbasi
8Bolurieh TTina
9Hosseini SESeyyedeh Esmat
10Chehrazi MMohammad
11Niknejadi MMaryam
12Baharvand HHossein
13Gharibdoost FFarhad
14Aghdami NNasser

Source PubMed

Download CSV of authors

Topics17

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Arthritis, RheumatoidMajor topic
Bone Marrow CellsMajor topic
Bone Marrow TransplantationMajor topic
Mesenchymal Stem Cell TransplantationMajor topic
Mesenchymal Stem CellsMajor topic
Osteoarthritis, KneeMajor topic
Adult
Aged
Double-Blind Method
Female
Humans
Injections, Intra-Articular
Knee Joint
Male
Middle Aged
Placebos
Treatment Outcome

Source PubMed

Download CSV of topics

Trials1

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

TrialTitleThe trial lists it asNamed in the paper's record
NCT01873625Transplantation of Bone Marrow Derived Mesenchymal Stem Cells in Affected Knee Osteoarthritis by Rheumatoid ArthritisDerived from the trialYes

Source ClinicalTrials.gov

Download CSV of trials

Cited by58

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 81 citations.

PMIDTitleJournalYearIn PapersSource
42808120Immunomodulatory Properties of Mesenchymal Stem Cells and Their Extracellular Vesicles: Potential Clinical Applications in Autoimmune Diseases.Cureus2026https://conductscience.org/library/papers/42808120PubMed
42523644Systemic regulation of rheumatoid arthritis by mesenchymal stem cells: from immune homeostasis to microbiota modulation.Front Immunol2026https://conductscience.org/library/papers/42523644PubMed
42038136The Role of Mesenchymal Stem/Stromal Cells and Their Extracellular Vesicles in Rheumatoid Arthritis.Galen Med J2024https://conductscience.org/library/papers/42038136PubMed
41782044Quantitative evaluation of mesenchymal stromal cell immunomodulatory potency and cost-effectiveness of cytokine licensing for translational application.J Transl Med2026https://conductscience.org/library/papers/41782044PubMed
41640457Stem Cell Therapy for Inflammatory Diseases: Progress, Challenges, and Future Directions.MedComm (2020)2026https://conductscience.org/library/papers/41640457PubMed
41398594Hierarchical therapeutic potential in the mesenchymal stem cell landscape.J Transl Med2025https://conductscience.org/library/papers/41398594PubMed
41310172Engineering CCR2/IFN-γ overexpression in enucleated mesenchymal stem cells enhances therapy for rheumatoid arthritis.Commun Biol2025https://conductscience.org/library/papers/41310172PubMed
40740529Molecular and therapeutic effects of mesenchymal stem cell-derived exosomes on autoimmune diseases.World J Stem Cells2025https://conductscience.org/library/papers/40740529PubMed
40671080Harnessing mesenchymal stem/stromal cells-based therapies for rheumatoid arthritis: mechanisms, clinical applications, and microenvironmental interactions.Stem Cell Res Ther2025https://conductscience.org/library/papers/40671080PubMed
40565230Advances in Regenerative Therapies for Inflammatory Arthritis: Exploring the Potential of Mesenchymal Stem Cells and Extracellular Vesicles.Int J Mol Sci2025https://conductscience.org/library/papers/40565230PubMed
40525425Modulating Proliferation, Migration and Differentiation of Mesenchymal Stem Cells Using Interleukins.Curr Stem Cell Res Ther2025https://conductscience.org/library/papers/40525425PubMed
39987230Human nasal turbinate stem cells with specific gene signatures (HAS2, CXCL1, KRTAP1-5, GSTT2B, and C4B) attenuate rheumatoid arthritis.Sci Rep2025https://conductscience.org/library/papers/39987230PubMed
39934871Efficacy and safety of mesenchymal stromal cell transplantation in the treatment of autoimmune and rheumatic immune diseases: a systematic review and meta-analysis of randomized controlled trials.Stem Cell Res Ther2025https://conductscience.org/library/papers/39934871PubMed
39767754Extracellular Vesicles from Mesenchymal Stem Cells: Potential as Therapeutics in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD).Biomedicines2024https://conductscience.org/library/papers/39767754PubMed
39360004Advanced therapy with mesenchymal stromal cells for knee osteoarthritis: Systematic review and meta-analysis of randomized controlled trials.J Orthop Translat2024https://conductscience.org/library/papers/39360004PubMed
39239074Combination treatment with interferon-γ may be a potential strategy to improve the efficacy of cytotherapy for rheumatoid arthritis: A network meta-analysis.J Res Med Sci2024https://conductscience.org/library/papers/39239074PubMed
39120313Cell-Based Therapy and Genome Editing as Emerging Therapeutic Approaches to Treat Rheumatoid Arthritis.Cells2024https://conductscience.org/library/papers/39120313PubMed
39026275Adipose-derived mesenchymal stem cell therapy for connective tissue diseases and complications.Inflamm Regen2024https://conductscience.org/library/papers/39026275PubMed
38477559Mesenchymal Stem Cells-Involved Strategies for Rheumatoid Arthritis Therapy.Adv Sci (Weinh)2024https://conductscience.org/library/papers/38477559PubMed
38366909A Phase I Dose-Escalation Clinical Trial to Assess the Safety and Efficacy of Umbilical Cord-Derived Mesenchymal Stromal Cells in Knee Osteoarthritis.Stem Cells Transl Med2024https://conductscience.org/library/papers/38366909PubMed

See all 58 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/29428486

GET https://conductscience.org/api/papers/v1/29428486/cited_by?page=2